| CRISPR/Cas9‐mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse Y Guan, Y Ma, Q Li, Z Sun, L Ma, L Wu, L Wang, L Zeng, Y Shao, Y Chen, ... EMBO molecular medicine 8 (5), 477-488, 2016 | 206 | 2016 |
| Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD BH Koehn, A Saha, C McDonald-Hyman, M Loschi, G Thangavelu, L Ma, ... Blood 134 (19), 1670-1682, 2019 | 59 | 2019 |
| Enhanced genome editing to ameliorate a genetic metabolic liver disease through co-delivery of adeno-associated virus receptor S Yin, L Ma, T Shao, M Zhang, Y Guan, L Wang, Y Hu, X Chen, H Han, ... Science China Life Sciences, 1-13, 2020 | 18 | 2020 |
| Generation of Human Myeloid Derived Suppressor Cells from Induced Pluripotent Stem Cells (IPSC) for Graft versus Host Disease Therapy L Ma, BH Koehn, KD Smith, A Mehta, KL Hippen, V Bob, BR Blazar MOLECULAR THERAPY 30 (4), 349-350, 2022 | | 2022 |
